Article
A loss-of-function variant of the antiviral molecule MAVS is associated with a subset of systemic lupus patients.
EMBO molecular medicine - 1 Mar 2011
Pothlichet Julien, Niewold Timothy B, Vitour Damien, Solhonne Brigitte, Crow Mary K, Si-Tahar Mustapha
Abstract excerpt
Dysregulation of the antiviral immune response may contribute to autoimmune diseases. Here, we hypothesized that altered expression or function of MAVS, a key molecule downstream of the viral sensors RIG-I and MDA-5, may impair antiviral cell signalling and thereby influence the risk for systemic lupus erythematosus (SLE), the prototype autoimmune disease. We used molecular techniques to screen non-synonymous...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
